| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |